Terrifying New Diabetes Drug Warning  

By Natalie Moore Posted June 6, 2017

Dear Living Well Daily Reader,

If you or someone you love suffers from diabetes, you know the threat of losing a limb is very real.

And you could lose your independence and mobility in the bargain.

But believe it or not, a certain diabetes drug could actually double your risk of foot or leg amputation.

And you may be taking it right now.

I’m taking about Invokana.

And it’s been linked to everything from kidney issues to heart problems in the past.

However, two recent clinical trials showed just how dangerous this drug truly is for your limbs.

The first trial showed that folks taking Invokana have twice the risk of experiencing a foot or leg amputation than those taking a placebo.

And this was no fluke.

A second study fully backed the results of the first one.

This means that not just one but two clinical trials show that taking Invokana DOUBLES your risk of losing your foot or leg.

It’s outrageous when you think about it — this medication increases your risk of the very thing it’s supposed to help prevent..

What’s worse? This is another example of the FDA approving a drug years before figuring out the long-term effects.

Now the FDA is going to require Invokana and its generic version canagliflozin, to come with a black box warning.

If you’re taking this drug, you need to talk to your doc about getting off of it and switching to something safer.

Live well,

Natalie Moore
Managing editor, Living Well Daily

Ed. Note: Please send your feedback: feedback@livingwelldaily.com – and click here to like us on Facebook.

Sources

^[1]
FDA Drug Safety Communication: FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR)

Written By Natalie Moore

Natalie Moore is a dedicated health researcher with a passion for finding healthy, natural, and science-based solutions. After a decade of direct healthcare experience in western and natural medicine, she was involved in public health research before joining Living Well Daily.

View More By Natalie Moore